Chemical & Engineering NewsSTING fever is sweeping through the cancer immunotherapy worldChemical & Engineering NewsThe crystal structure of human STING, with the agonist ADU-S100, currently in a Phase I clinical trial from Aduro Biotech and Novartis. … Continue reading
Medical XpressEnabling technology for emerging gene therapiesMedical XpressDNA insertion, or transfection, which is of most interest in gene therapy, is significantly more challenging. Yet the combined application of mechanical and electrical forces pi… Continue reading
OncLive |
Expert Highlights Immunotherapy Use in Stage III NSCLC
OncLive OncLive: Can you highlight potential uses of immunotherapy for stage III locally advanced disease? Schwartz: Immunotherapy is a very exciting topic right now, and we’ve seen incredible promise with it. We’re still trying to differentiate which agents … |
|
First Longeveron Mesenchymal Stem Cell Treatment Administered to an Infant with Rare Heart Condition as Part of …
PR Newswire (press release) MIAMI, Feb. 27, 2018 /PRNewswire/ — Longeveron announced that its pioneering clinical trial to treat infants with Hypoplastic Left Heart Syndrome officially started with the first patient receiving the company’s mesenchymal stem cell therapy in a … |